nodes	percent_of_prediction	percent_of_DWPC	metapath
Valaciclovir—SLC22A8—Pravastatin—atherosclerosis	0.308	0.589	CbGbCtD
Valaciclovir—SLC22A6—Pravastatin—atherosclerosis	0.215	0.411	CbGbCtD
Valaciclovir—SLC10A2—Bile acid and bile salt metabolism—CYP7A1—atherosclerosis	0.00583	0.0721	CbGpPWpGaD
Valaciclovir—SLC10A2—Bile acid and bile salt metabolism—CYP27A1—atherosclerosis	0.00539	0.0666	CbGpPWpGaD
Valaciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—CSF1R—atherosclerosis	0.0041	0.0506	CbGpPWpGaD
Valaciclovir—SLC10A2—Recycling of bile acids and salts—ALB—atherosclerosis	0.00297	0.0367	CbGpPWpGaD
Valaciclovir—SLC10A2—Orphan transporters—CYP7A1—atherosclerosis	0.0025	0.0308	CbGpPWpGaD
Valaciclovir—SLC10A2—Orphan transporters—CETP—atherosclerosis	0.0016	0.0198	CbGpPWpGaD
Valaciclovir—SLC10A2—Bile acid and bile salt metabolism—ALB—atherosclerosis	0.00155	0.0192	CbGpPWpGaD
Valaciclovir—Angioedema—Rosuvastatin—atherosclerosis	0.00142	0.00358	CcSEcCtD
Valaciclovir—Hepatitis—Simvastatin—atherosclerosis	0.00141	0.00357	CcSEcCtD
Valaciclovir—SLC10A2—Orphan transporters—PLAT—atherosclerosis	0.00141	0.0174	CbGpPWpGaD
Valaciclovir—Stomatitis—Niacin—atherosclerosis	0.00141	0.00356	CcSEcCtD
Valaciclovir—Erythema multiforme—Ezetimibe—atherosclerosis	0.0014	0.00354	CcSEcCtD
Valaciclovir—Urinary tract infection—Pravastatin—atherosclerosis	0.00138	0.00349	CcSEcCtD
Valaciclovir—Chills—Lovastatin—atherosclerosis	0.00136	0.00342	CcSEcCtD
Valaciclovir—Cough—Rosuvastatin—atherosclerosis	0.00135	0.00342	CcSEcCtD
Valaciclovir—Immune system disorder—Ezetimibe—atherosclerosis	0.00134	0.00338	CcSEcCtD
Valaciclovir—Erythema multiforme—Simvastatin—atherosclerosis	0.00134	0.00338	CcSEcCtD
Valaciclovir—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00134	0.00337	CcSEcCtD
Valaciclovir—Sinusitis—Pravastatin—atherosclerosis	0.00133	0.00337	CcSEcCtD
Valaciclovir—Alopecia—Lovastatin—atherosclerosis	0.00133	0.00337	CcSEcCtD
Valaciclovir—Arthralgia—Rosuvastatin—atherosclerosis	0.00132	0.00334	CcSEcCtD
Valaciclovir—Myalgia—Rosuvastatin—atherosclerosis	0.00132	0.00334	CcSEcCtD
Valaciclovir—Alopecia—Ezetimibe—atherosclerosis	0.00131	0.00331	CcSEcCtD
Valaciclovir—Rhinitis—Niacin—atherosclerosis	0.0013	0.00329	CcSEcCtD
Valaciclovir—Hepatitis—Niacin—atherosclerosis	0.0013	0.00328	CcSEcCtD
Valaciclovir—Flatulence—Lovastatin—atherosclerosis	0.0013	0.00327	CcSEcCtD
Valaciclovir—Rhinitis—Pravastatin—atherosclerosis	0.00128	0.00324	CcSEcCtD
Valaciclovir—Oedema peripheral—Niacin—atherosclerosis	0.00128	0.00323	CcSEcCtD
Valaciclovir—Hepatitis—Pravastatin—atherosclerosis	0.00128	0.00323	CcSEcCtD
Valaciclovir—Confusional state—Rosuvastatin—atherosclerosis	0.00128	0.00323	CcSEcCtD
Valaciclovir—Back pain—Lovastatin—atherosclerosis	0.00127	0.00321	CcSEcCtD
Valaciclovir—Flatulence—Ezetimibe—atherosclerosis	0.00127	0.00321	CcSEcCtD
Valaciclovir—Pharyngitis—Pravastatin—atherosclerosis	0.00127	0.0032	CcSEcCtD
Valaciclovir—Chills—Simvastatin—atherosclerosis	0.00127	0.0032	CcSEcCtD
Valaciclovir—Infection—Rosuvastatin—atherosclerosis	0.00126	0.00318	CcSEcCtD
Valaciclovir—Alopecia—Simvastatin—atherosclerosis	0.00125	0.00315	CcSEcCtD
Valaciclovir—Back pain—Ezetimibe—atherosclerosis	0.00125	0.00315	CcSEcCtD
Valaciclovir—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00124	0.00314	CcSEcCtD
Valaciclovir—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00124	0.00313	CcSEcCtD
Valaciclovir—Tremor—Lovastatin—atherosclerosis	0.00123	0.00311	CcSEcCtD
Valaciclovir—Flatulence—Simvastatin—atherosclerosis	0.00121	0.00306	CcSEcCtD
Valaciclovir—Erythema multiforme—Pravastatin—atherosclerosis	0.00121	0.00305	CcSEcCtD
Valaciclovir—Angioedema—Lovastatin—atherosclerosis	0.0012	0.00304	CcSEcCtD
Valaciclovir—SLC10A2—Orphan transporters—PLG—atherosclerosis	0.0012	0.0148	CbGpPWpGaD
Valaciclovir—Anaemia—Ezetimibe—atherosclerosis	0.00119	0.00301	CcSEcCtD
Valaciclovir—Angioedema—Ezetimibe—atherosclerosis	0.00118	0.00298	CcSEcCtD
Valaciclovir—Leukopenia—Lovastatin—atherosclerosis	0.00118	0.00297	CcSEcCtD
Valaciclovir—Chills—Niacin—atherosclerosis	0.00116	0.00294	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00115	0.00292	CcSEcCtD
Valaciclovir—Tremor—Simvastatin—atherosclerosis	0.00115	0.00291	CcSEcCtD
Valaciclovir—Alopecia—Niacin—atherosclerosis	0.00115	0.0029	CcSEcCtD
Valaciclovir—Chills—Pravastatin—atherosclerosis	0.00115	0.0029	CcSEcCtD
Valaciclovir—Insomnia—Rosuvastatin—atherosclerosis	0.00115	0.00289	CcSEcCtD
Valaciclovir—Paraesthesia—Rosuvastatin—atherosclerosis	0.00114	0.00287	CcSEcCtD
Valaciclovir—Anaemia—Simvastatin—atherosclerosis	0.00114	0.00287	CcSEcCtD
Valaciclovir—Alopecia—Pravastatin—atherosclerosis	0.00113	0.00285	CcSEcCtD
Valaciclovir—Cough—Ezetimibe—atherosclerosis	0.00113	0.00284	CcSEcCtD
Valaciclovir—Angioedema—Simvastatin—atherosclerosis	0.00112	0.00284	CcSEcCtD
Valaciclovir—Myalgia—Lovastatin—atherosclerosis	0.00112	0.00283	CcSEcCtD
Valaciclovir—Chest pain—Lovastatin—atherosclerosis	0.00112	0.00283	CcSEcCtD
Valaciclovir—Arthralgia—Lovastatin—atherosclerosis	0.00112	0.00283	CcSEcCtD
Valaciclovir—Dyspepsia—Rosuvastatin—atherosclerosis	0.00111	0.00282	CcSEcCtD
Valaciclovir—Hypertension—Ezetimibe—atherosclerosis	0.00111	0.00281	CcSEcCtD
Valaciclovir—Flatulence—Niacin—atherosclerosis	0.00111	0.00281	CcSEcCtD
Valaciclovir—Tension—Niacin—atherosclerosis	0.00111	0.0028	CcSEcCtD
Valaciclovir—Leukopenia—Simvastatin—atherosclerosis	0.0011	0.00278	CcSEcCtD
Valaciclovir—Chest pain—Ezetimibe—atherosclerosis	0.0011	0.00277	CcSEcCtD
Valaciclovir—Arthralgia—Ezetimibe—atherosclerosis	0.0011	0.00277	CcSEcCtD
Valaciclovir—Myalgia—Ezetimibe—atherosclerosis	0.0011	0.00277	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	0.0011	0.0136	CbGpPWpGaD
Valaciclovir—Nervousness—Niacin—atherosclerosis	0.0011	0.00277	CcSEcCtD
Valaciclovir—Flatulence—Pravastatin—atherosclerosis	0.0011	0.00277	CcSEcCtD
Valaciclovir—Dry mouth—Lovastatin—atherosclerosis	0.00109	0.00277	CcSEcCtD
Valaciclovir—Tension—Pravastatin—atherosclerosis	0.00109	0.00276	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00109	0.00276	CcSEcCtD
Valaciclovir—Pain—Rosuvastatin—atherosclerosis	0.00108	0.00274	CcSEcCtD
Valaciclovir—Constipation—Rosuvastatin—atherosclerosis	0.00108	0.00274	CcSEcCtD
Valaciclovir—Confusional state—Lovastatin—atherosclerosis	0.00108	0.00273	CcSEcCtD
Valaciclovir—Nervousness—Pravastatin—atherosclerosis	0.00108	0.00273	CcSEcCtD
Valaciclovir—Dry mouth—Ezetimibe—atherosclerosis	0.00107	0.00271	CcSEcCtD
Valaciclovir—Anaphylactic shock—Lovastatin—atherosclerosis	0.00107	0.00271	CcSEcCtD
Valaciclovir—Infection—Lovastatin—atherosclerosis	0.00107	0.00269	CcSEcCtD
Valaciclovir—Confusional state—Ezetimibe—atherosclerosis	0.00106	0.00268	CcSEcCtD
Valaciclovir—SLC10A2—Orphan transporters—APOB—atherosclerosis	0.00106	0.0131	CbGpPWpGaD
Valaciclovir—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00105	0.00266	CcSEcCtD
Valaciclovir—Thrombocytopenia—Lovastatin—atherosclerosis	0.00105	0.00265	CcSEcCtD
Valaciclovir—Myalgia—Simvastatin—atherosclerosis	0.00105	0.00265	CcSEcCtD
Valaciclovir—Chest pain—Simvastatin—atherosclerosis	0.00105	0.00265	CcSEcCtD
Valaciclovir—Arthralgia—Simvastatin—atherosclerosis	0.00105	0.00265	CcSEcCtD
Valaciclovir—Infection—Ezetimibe—atherosclerosis	0.00105	0.00264	CcSEcCtD
Valaciclovir—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00104	0.00264	CcSEcCtD
Valaciclovir—Tremor—Pravastatin—atherosclerosis	0.00104	0.00263	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00104	0.00262	CcSEcCtD
Valaciclovir—Nervous system disorder—Ezetimibe—atherosclerosis	0.00103	0.00261	CcSEcCtD
Valaciclovir—Angioedema—Niacin—atherosclerosis	0.00103	0.00261	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	0.00103	0.0127	CbGpPWpGaD
Valaciclovir—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00103	0.0026	CcSEcCtD
Valaciclovir—Anaemia—Pravastatin—atherosclerosis	0.00103	0.0026	CcSEcCtD
Valaciclovir—Anorexia—Lovastatin—atherosclerosis	0.00102	0.00258	CcSEcCtD
Valaciclovir—Skin disorder—Ezetimibe—atherosclerosis	0.00102	0.00258	CcSEcCtD
Valaciclovir—Angioedema—Pravastatin—atherosclerosis	0.00102	0.00257	CcSEcCtD
Valaciclovir—Confusional state—Simvastatin—atherosclerosis	0.00101	0.00256	CcSEcCtD
Valaciclovir—Leukopenia—Niacin—atherosclerosis	0.00101	0.00255	CcSEcCtD
Valaciclovir—Urticaria—Rosuvastatin—atherosclerosis	0.00101	0.00254	CcSEcCtD
Valaciclovir—Oedema—Simvastatin—atherosclerosis	0.001	0.00254	CcSEcCtD
Valaciclovir—Anaphylactic shock—Simvastatin—atherosclerosis	0.001	0.00254	CcSEcCtD
Valaciclovir—Abdominal pain—Rosuvastatin—atherosclerosis	0.001	0.00253	CcSEcCtD
Valaciclovir—Infection—Simvastatin—atherosclerosis	0.000997	0.00252	CcSEcCtD
Valaciclovir—Leukopenia—Pravastatin—atherosclerosis	0.000995	0.00251	CcSEcCtD
Valaciclovir—Cough—Niacin—atherosclerosis	0.000985	0.00249	CcSEcCtD
Valaciclovir—Thrombocytopenia—Simvastatin—atherosclerosis	0.000983	0.00248	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000978	0.00247	CcSEcCtD
Valaciclovir—Insomnia—Lovastatin—atherosclerosis	0.00097	0.00245	CcSEcCtD
Valaciclovir—Cough—Pravastatin—atherosclerosis	0.00097	0.00245	CcSEcCtD
Valaciclovir—Paraesthesia—Lovastatin—atherosclerosis	0.000963	0.00243	CcSEcCtD
Valaciclovir—Myalgia—Niacin—atherosclerosis	0.000961	0.00243	CcSEcCtD
Valaciclovir—Arthralgia—Niacin—atherosclerosis	0.000961	0.00243	CcSEcCtD
Valaciclovir—Hypertension—Pravastatin—atherosclerosis	0.00096	0.00243	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000959	0.00242	CcSEcCtD
Valaciclovir—Anorexia—Simvastatin—atherosclerosis	0.000957	0.00242	CcSEcCtD
Valaciclovir—Dyspnoea—Lovastatin—atherosclerosis	0.000957	0.00242	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000955	0.00241	CcSEcCtD
Valaciclovir—Insomnia—Ezetimibe—atherosclerosis	0.000952	0.00241	CcSEcCtD
Valaciclovir—Myalgia—Pravastatin—atherosclerosis	0.000947	0.00239	CcSEcCtD
Valaciclovir—Chest pain—Pravastatin—atherosclerosis	0.000947	0.00239	CcSEcCtD
Valaciclovir—Arthralgia—Pravastatin—atherosclerosis	0.000947	0.00239	CcSEcCtD
Valaciclovir—Paraesthesia—Ezetimibe—atherosclerosis	0.000945	0.00239	CcSEcCtD
Valaciclovir—Dyspepsia—Lovastatin—atherosclerosis	0.000944	0.00239	CcSEcCtD
Valaciclovir—Dry mouth—Niacin—atherosclerosis	0.00094	0.00238	CcSEcCtD
Valaciclovir—Dyspnoea—Ezetimibe—atherosclerosis	0.000938	0.00237	CcSEcCtD
Valaciclovir—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000933	0.00236	CcSEcCtD
Valaciclovir—Decreased appetite—Lovastatin—atherosclerosis	0.000933	0.00236	CcSEcCtD
Valaciclovir—Dyspepsia—Ezetimibe—atherosclerosis	0.000926	0.00234	CcSEcCtD
Valaciclovir—Fatigue—Lovastatin—atherosclerosis	0.000925	0.00234	CcSEcCtD
Valaciclovir—Anaphylactic shock—Niacin—atherosclerosis	0.000922	0.00233	CcSEcCtD
Valaciclovir—Oedema—Niacin—atherosclerosis	0.000922	0.00233	CcSEcCtD
Valaciclovir—Pain—Lovastatin—atherosclerosis	0.000918	0.00232	CcSEcCtD
Valaciclovir—Constipation—Lovastatin—atherosclerosis	0.000918	0.00232	CcSEcCtD
Valaciclovir—Confusional state—Pravastatin—atherosclerosis	0.000915	0.00231	CcSEcCtD
Valaciclovir—Decreased appetite—Ezetimibe—atherosclerosis	0.000915	0.00231	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000914	0.00231	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000909	0.0023	CcSEcCtD
Valaciclovir—Asthenia—Rosuvastatin—atherosclerosis	0.000908	0.0023	CcSEcCtD
Valaciclovir—Insomnia—Simvastatin—atherosclerosis	0.000908	0.00229	CcSEcCtD
Valaciclovir—Oedema—Pravastatin—atherosclerosis	0.000907	0.00229	CcSEcCtD
Valaciclovir—Anaphylactic shock—Pravastatin—atherosclerosis	0.000907	0.00229	CcSEcCtD
Valaciclovir—Fatigue—Ezetimibe—atherosclerosis	0.000907	0.00229	CcSEcCtD
Valaciclovir—Infection—Pravastatin—atherosclerosis	0.000901	0.00228	CcSEcCtD
Valaciclovir—Paraesthesia—Simvastatin—atherosclerosis	0.000901	0.00228	CcSEcCtD
Valaciclovir—Pain—Ezetimibe—atherosclerosis	0.0009	0.00227	CcSEcCtD
Valaciclovir—Constipation—Ezetimibe—atherosclerosis	0.0009	0.00227	CcSEcCtD
Valaciclovir—Tachycardia—Niacin—atherosclerosis	0.000899	0.00227	CcSEcCtD
Valaciclovir—Pruritus—Rosuvastatin—atherosclerosis	0.000896	0.00226	CcSEcCtD
Valaciclovir—Skin disorder—Niacin—atherosclerosis	0.000895	0.00226	CcSEcCtD
Valaciclovir—Dyspnoea—Simvastatin—atherosclerosis	0.000895	0.00226	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	0.000894	0.011	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	0.000894	0.011	CbGpPWpGaD
Valaciclovir—SLC10A2—Orphan transporters—PPARA—atherosclerosis	0.000893	0.011	CbGpPWpGaD
Valaciclovir—Thrombocytopenia—Pravastatin—atherosclerosis	0.000888	0.00225	CcSEcCtD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.000887	0.011	CbGpPWpGaD
Valaciclovir—Feeling abnormal—Lovastatin—atherosclerosis	0.000884	0.00223	CcSEcCtD
Valaciclovir—Dyspepsia—Simvastatin—atherosclerosis	0.000883	0.00223	CcSEcCtD
Valaciclovir—Anorexia—Niacin—atherosclerosis	0.000878	0.00222	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000877	0.00222	CcSEcCtD
Valaciclovir—Decreased appetite—Simvastatin—atherosclerosis	0.000872	0.0022	CcSEcCtD
Valaciclovir—Feeling abnormal—Ezetimibe—atherosclerosis	0.000867	0.00219	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000866	0.00219	CcSEcCtD
Valaciclovir—Diarrhoea—Rosuvastatin—atherosclerosis	0.000866	0.00219	CcSEcCtD
Valaciclovir—Fatigue—Simvastatin—atherosclerosis	0.000865	0.00219	CcSEcCtD
Valaciclovir—Anorexia—Pravastatin—atherosclerosis	0.000865	0.00219	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000861	0.00217	CcSEcCtD
Valaciclovir—Constipation—Simvastatin—atherosclerosis	0.000858	0.00217	CcSEcCtD
Valaciclovir—Pain—Simvastatin—atherosclerosis	0.000858	0.00217	CcSEcCtD
Valaciclovir—Urticaria—Lovastatin—atherosclerosis	0.000852	0.00215	CcSEcCtD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.00085	0.0105	CbGpPWpGaD
Valaciclovir—Abdominal pain—Lovastatin—atherosclerosis	0.000848	0.00214	CcSEcCtD
Valaciclovir—Body temperature increased—Lovastatin—atherosclerosis	0.000848	0.00214	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00084	0.00212	CcSEcCtD
Valaciclovir—Dizziness—Rosuvastatin—atherosclerosis	0.000837	0.00212	CcSEcCtD
Valaciclovir—Urticaria—Ezetimibe—atherosclerosis	0.000836	0.00211	CcSEcCtD
Valaciclovir—Insomnia—Niacin—atherosclerosis	0.000833	0.00211	CcSEcCtD
Valaciclovir—Abdominal pain—Ezetimibe—atherosclerosis	0.000832	0.0021	CcSEcCtD
Valaciclovir—Body temperature increased—Ezetimibe—atherosclerosis	0.000832	0.0021	CcSEcCtD
Valaciclovir—Paraesthesia—Niacin—atherosclerosis	0.000827	0.00209	CcSEcCtD
Valaciclovir—Feeling abnormal—Simvastatin—atherosclerosis	0.000827	0.00209	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000827	0.00209	CcSEcCtD
Valaciclovir—Dyspnoea—Niacin—atherosclerosis	0.000822	0.00208	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000821	0.00207	CcSEcCtD
Valaciclovir—Insomnia—Pravastatin—atherosclerosis	0.000821	0.00207	CcSEcCtD
Valaciclovir—Somnolence—Niacin—atherosclerosis	0.000819	0.00207	CcSEcCtD
Valaciclovir—Paraesthesia—Pravastatin—atherosclerosis	0.000815	0.00206	CcSEcCtD
Valaciclovir—Dyspepsia—Niacin—atherosclerosis	0.000811	0.00205	CcSEcCtD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.000811	0.01	CbGpPWpGaD
Valaciclovir—Dyspnoea—Pravastatin—atherosclerosis	0.000809	0.00204	CcSEcCtD
Valaciclovir—Decreased appetite—Niacin—atherosclerosis	0.000801	0.00202	CcSEcCtD
Valaciclovir—Dyspepsia—Pravastatin—atherosclerosis	0.000799	0.00202	CcSEcCtD
Valaciclovir—Rash—Rosuvastatin—atherosclerosis	0.000798	0.00202	CcSEcCtD
Valaciclovir—Dermatitis—Rosuvastatin—atherosclerosis	0.000798	0.00202	CcSEcCtD
Valaciclovir—Urticaria—Simvastatin—atherosclerosis	0.000797	0.00201	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Niacin—atherosclerosis	0.000796	0.00201	CcSEcCtD
Valaciclovir—Abdominal pain—Simvastatin—atherosclerosis	0.000793	0.002	CcSEcCtD
Valaciclovir—Body temperature increased—Simvastatin—atherosclerosis	0.000793	0.002	CcSEcCtD
Valaciclovir—Headache—Rosuvastatin—atherosclerosis	0.000793	0.002	CcSEcCtD
Valaciclovir—Hypersensitivity—Lovastatin—atherosclerosis	0.000791	0.002	CcSEcCtD
Valaciclovir—Decreased appetite—Pravastatin—atherosclerosis	0.000789	0.00199	CcSEcCtD
Valaciclovir—Pain—Niacin—atherosclerosis	0.000788	0.00199	CcSEcCtD
Valaciclovir—Fatigue—Pravastatin—atherosclerosis	0.000782	0.00198	CcSEcCtD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.000777	0.00961	CbGpPWpGaD
Valaciclovir—Constipation—Pravastatin—atherosclerosis	0.000776	0.00196	CcSEcCtD
Valaciclovir—Pain—Pravastatin—atherosclerosis	0.000776	0.00196	CcSEcCtD
Valaciclovir—Hypersensitivity—Ezetimibe—atherosclerosis	0.000775	0.00196	CcSEcCtD
Valaciclovir—SLC6A14—NRF2 pathway—HMOX1—atherosclerosis	0.000771	0.00953	CbGpPWpGaD
Valaciclovir—Asthenia—Lovastatin—atherosclerosis	0.00077	0.00195	CcSEcCtD
Valaciclovir—Pruritus—Lovastatin—atherosclerosis	0.000759	0.00192	CcSEcCtD
Valaciclovir—Asthenia—Ezetimibe—atherosclerosis	0.000755	0.00191	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Niacin—atherosclerosis	0.000754	0.0019	CcSEcCtD
Valaciclovir—Nausea—Rosuvastatin—atherosclerosis	0.000752	0.0019	CcSEcCtD
Valaciclovir—Feeling abnormal—Pravastatin—atherosclerosis	0.000748	0.00189	CcSEcCtD
Valaciclovir—Pruritus—Ezetimibe—atherosclerosis	0.000745	0.00188	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000742	0.00188	CcSEcCtD
Valaciclovir—Hypersensitivity—Simvastatin—atherosclerosis	0.000739	0.00187	CcSEcCtD
Valaciclovir—Diarrhoea—Lovastatin—atherosclerosis	0.000734	0.00186	CcSEcCtD
Valaciclovir—Urticaria—Niacin—atherosclerosis	0.000732	0.00185	CcSEcCtD
Valaciclovir—Body temperature increased—Niacin—atherosclerosis	0.000728	0.00184	CcSEcCtD
Valaciclovir—Abdominal pain—Niacin—atherosclerosis	0.000728	0.00184	CcSEcCtD
Valaciclovir—Urticaria—Pravastatin—atherosclerosis	0.000721	0.00182	CcSEcCtD
Valaciclovir—Asthenia—Simvastatin—atherosclerosis	0.00072	0.00182	CcSEcCtD
Valaciclovir—Diarrhoea—Ezetimibe—atherosclerosis	0.00072	0.00182	CcSEcCtD
Valaciclovir—SLC6A14—NRF2 pathway—GSTM1—atherosclerosis	0.000718	0.00888	CbGpPWpGaD
Valaciclovir—Body temperature increased—Pravastatin—atherosclerosis	0.000717	0.00181	CcSEcCtD
Valaciclovir—Abdominal pain—Pravastatin—atherosclerosis	0.000717	0.00181	CcSEcCtD
Valaciclovir—Pruritus—Simvastatin—atherosclerosis	0.00071	0.00179	CcSEcCtD
Valaciclovir—Dizziness—Lovastatin—atherosclerosis	0.00071	0.00179	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.000707	0.00873	CbGpPWpGaD
Valaciclovir—Dizziness—Ezetimibe—atherosclerosis	0.000696	0.00176	CcSEcCtD
Valaciclovir—SLC6A14—NRF2 pathway—AGER—atherosclerosis	0.000693	0.00856	CbGpPWpGaD
Valaciclovir—Diarrhoea—Simvastatin—atherosclerosis	0.000687	0.00174	CcSEcCtD
Valaciclovir—Vomiting—Lovastatin—atherosclerosis	0.000682	0.00172	CcSEcCtD
Valaciclovir—Hypersensitivity—Niacin—atherosclerosis	0.000679	0.00172	CcSEcCtD
Valaciclovir—Rash—Lovastatin—atherosclerosis	0.000677	0.00171	CcSEcCtD
Valaciclovir—Dermatitis—Lovastatin—atherosclerosis	0.000676	0.00171	CcSEcCtD
Valaciclovir—Headache—Lovastatin—atherosclerosis	0.000672	0.0017	CcSEcCtD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—ABCG1—atherosclerosis	0.000672	0.0083	CbGpPWpGaD
Valaciclovir—Vomiting—Ezetimibe—atherosclerosis	0.000669	0.00169	CcSEcCtD
Valaciclovir—Hypersensitivity—Pravastatin—atherosclerosis	0.000668	0.00169	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	0.000664	0.00821	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	0.000664	0.00821	CbGpPWpGaD
Valaciclovir—Dizziness—Simvastatin—atherosclerosis	0.000664	0.00168	CcSEcCtD
Valaciclovir—Rash—Ezetimibe—atherosclerosis	0.000664	0.00168	CcSEcCtD
Valaciclovir—Dermatitis—Ezetimibe—atherosclerosis	0.000663	0.00168	CcSEcCtD
Valaciclovir—Asthenia—Niacin—atherosclerosis	0.000661	0.00167	CcSEcCtD
Valaciclovir—Headache—Ezetimibe—atherosclerosis	0.000659	0.00167	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	0.000652	0.00806	CbGpPWpGaD
Valaciclovir—Pruritus—Niacin—atherosclerosis	0.000652	0.00165	CcSEcCtD
Valaciclovir—Asthenia—Pravastatin—atherosclerosis	0.000651	0.00165	CcSEcCtD
Valaciclovir—Pruritus—Pravastatin—atherosclerosis	0.000642	0.00162	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	0.000641	0.00792	CbGpPWpGaD
Valaciclovir—Vomiting—Simvastatin—atherosclerosis	0.000638	0.00161	CcSEcCtD
Valaciclovir—Nausea—Lovastatin—atherosclerosis	0.000637	0.00161	CcSEcCtD
Valaciclovir—Rash—Simvastatin—atherosclerosis	0.000633	0.0016	CcSEcCtD
Valaciclovir—Dermatitis—Simvastatin—atherosclerosis	0.000632	0.0016	CcSEcCtD
Valaciclovir—Diarrhoea—Niacin—atherosclerosis	0.000631	0.00159	CcSEcCtD
Valaciclovir—Headache—Simvastatin—atherosclerosis	0.000629	0.00159	CcSEcCtD
Valaciclovir—Nausea—Ezetimibe—atherosclerosis	0.000625	0.00158	CcSEcCtD
Valaciclovir—Diarrhoea—Pravastatin—atherosclerosis	0.000621	0.00157	CcSEcCtD
Valaciclovir—SLC6A14—NRF2 pathway—PDGFB—atherosclerosis	0.000618	0.00764	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—ABCG1—atherosclerosis	0.000615	0.0076	CbGpPWpGaD
Valaciclovir—Dizziness—Niacin—atherosclerosis	0.000609	0.00154	CcSEcCtD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	0.000609	0.00753	CbGpPWpGaD
Valaciclovir—Dizziness—Pravastatin—atherosclerosis	0.0006	0.00152	CcSEcCtD
Valaciclovir—Nausea—Simvastatin—atherosclerosis	0.000596	0.00151	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	0.000592	0.00732	CbGpPWpGaD
Valaciclovir—Vomiting—Niacin—atherosclerosis	0.000586	0.00148	CcSEcCtD
Valaciclovir—Rash—Niacin—atherosclerosis	0.000581	0.00147	CcSEcCtD
Valaciclovir—Dermatitis—Niacin—atherosclerosis	0.000581	0.00147	CcSEcCtD
Valaciclovir—Headache—Niacin—atherosclerosis	0.000577	0.00146	CcSEcCtD
Valaciclovir—Vomiting—Pravastatin—atherosclerosis	0.000577	0.00146	CcSEcCtD
Valaciclovir—Rash—Pravastatin—atherosclerosis	0.000572	0.00145	CcSEcCtD
Valaciclovir—Dermatitis—Pravastatin—atherosclerosis	0.000572	0.00144	CcSEcCtD
Valaciclovir—Headache—Pravastatin—atherosclerosis	0.000568	0.00144	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	0.000561	0.00694	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	0.000561	0.00694	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	0.000561	0.00694	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	0.000561	0.00694	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	0.000557	0.00689	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	0.000555	0.00685	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—TRPV1—atherosclerosis	0.000548	0.00677	CbGpPWpGaD
Valaciclovir—Nausea—Niacin—atherosclerosis	0.000547	0.00138	CcSEcCtD
Valaciclovir—Nausea—Pravastatin—atherosclerosis	0.000539	0.00136	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	0.000536	0.00662	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—ABCG5—atherosclerosis	0.000527	0.00652	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	0.000513	0.00635	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—TRPV1—atherosclerosis	0.000501	0.00619	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	0.000494	0.00611	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—LDLRAP1—atherosclerosis	0.000488	0.00604	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—ABCG5—atherosclerosis	0.000482	0.00596	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	0.000477	0.0059	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PLTP—atherosclerosis	0.000459	0.00567	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	0.000425	0.00526	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	0.000423	0.00523	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	0.00042	0.00519	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	0.00041	0.00507	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ABCG8—atherosclerosis	0.000398	0.00492	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—LTA4H—atherosclerosis	0.000398	0.00492	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	0.000393	0.00486	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—CETP—atherosclerosis	0.00039	0.00482	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.000384	0.00474	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	0.000371	0.00459	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.000368	0.00454	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—CETP—atherosclerosis	0.000357	0.00441	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.000356	0.0044	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—PLAT—atherosclerosis	0.000344	0.00425	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.000341	0.00422	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	0.000331	0.00409	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.000317	0.00391	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ABCG1—atherosclerosis	0.000315	0.00389	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—PLAT—atherosclerosis	0.000315	0.00389	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.000304	0.00375	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—FABP4—atherosclerosis	0.000296	0.00366	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—LCAT—atherosclerosis	0.000296	0.00366	CbGpPWpGaD
Valaciclovir—SLC6A14—NRF2 pathway—TGFB1—atherosclerosis	0.000293	0.00362	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—PLG—atherosclerosis	0.000292	0.00361	CbGpPWpGaD
Valaciclovir—SLC6A14—SLC-mediated transmembrane transport—ALB—atherosclerosis	0.000292	0.00361	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ABCG1—atherosclerosis	0.000291	0.00359	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—APOA4—atherosclerosis	0.00029	0.00359	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CYP7A1—atherosclerosis	0.000285	0.00353	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	0.000272	0.00336	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—HMOX1—atherosclerosis	0.00027	0.00334	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ABCG1—atherosclerosis	0.00027	0.00333	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—PLG—atherosclerosis	0.000268	0.00331	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.000264	0.00327	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CYP27A1—atherosclerosis	0.000264	0.00326	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	0.000264	0.00326	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	0.00026	0.00321	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—APOB—atherosclerosis	0.000259	0.0032	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.000253	0.00313	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	0.000253	0.00313	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—APOA2—atherosclerosis	0.00025	0.00309	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ALOX5AP—atherosclerosis	0.00025	0.00309	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PLA2G2A—atherosclerosis	0.00025	0.00309	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ALOX15—atherosclerosis	0.00025	0.00309	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ABCG5—atherosclerosis	0.000247	0.00305	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—HMOX1—atherosclerosis	0.000247	0.00305	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	0.000247	0.00305	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	0.000245	0.00302	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ABCG1—atherosclerosis	0.00024	0.00297	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—LPA—atherosclerosis	0.000239	0.00295	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—TRPV1—atherosclerosis	0.000237	0.00293	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—APOB—atherosclerosis	0.000236	0.00292	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—BGN—atherosclerosis	0.000231	0.00285	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	0.000229	0.00283	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—APOA5—atherosclerosis	0.000229	0.00283	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ABCG5—atherosclerosis	0.000228	0.00282	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	0.000222	0.00274	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PLA2G1B—atherosclerosis	0.00022	0.00272	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—TRPV1—atherosclerosis	0.00022	0.00272	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—PPARA—atherosclerosis	0.000218	0.00269	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	0.000218	0.00269	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	0.000218	0.00269	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	0.000216	0.00266	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	0.000215	0.00266	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ALOX5—atherosclerosis	0.000213	0.00263	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ABCG5—atherosclerosis	0.000212	0.00262	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—APOA1—atherosclerosis	0.000205	0.00253	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ABCG1—atherosclerosis	0.0002	0.00247	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—PPARA—atherosclerosis	0.000199	0.00246	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	0.000196	0.00243	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—TRPV1—atherosclerosis	0.000196	0.00242	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—NAMPT—atherosclerosis	0.000191	0.00236	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	0.00019	0.00234	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—LIPC—atherosclerosis	0.000189	0.00234	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—APOC3—atherosclerosis	0.000188	0.00233	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ABCG5—atherosclerosis	0.000188	0.00233	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—LDLR—atherosclerosis	0.000187	0.00231	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—APOA1—atherosclerosis	0.000187	0.00231	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CETP—atherosclerosis	0.000183	0.00226	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	0.000182	0.00224	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—SCARB1—atherosclerosis	0.000175	0.00216	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	0.00017	0.00211	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—CETP—atherosclerosis	0.000169	0.00209	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—HMGCR—atherosclerosis	0.000165	0.00204	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—TRPV1—atherosclerosis	0.000163	0.00202	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—ALB—atherosclerosis	0.000162	0.002	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ABCG5—atherosclerosis	0.000157	0.00194	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—CETP—atherosclerosis	0.000157	0.00194	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	0.000149	0.00184	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—PLAT—atherosclerosis	0.000149	0.00184	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—ALB—atherosclerosis	0.000148	0.00183	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ABCA1—atherosclerosis	0.000147	0.00182	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—CETP—atherosclerosis	0.000139	0.00172	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—PLAT—atherosclerosis	0.000138	0.00171	CbGpPWpGaD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—ALB—atherosclerosis	0.000138	0.00171	CbGpPWpGaD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—ALB—atherosclerosis	0.000128	0.00158	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—PLG—atherosclerosis	0.000127	0.00156	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—HMOX1—atherosclerosis	0.000126	0.00156	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—PLAT—atherosclerosis	0.000123	0.00152	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—APOB—atherosclerosis	0.000121	0.0015	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GSTM1—atherosclerosis	0.000118	0.00146	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—PLG—atherosclerosis	0.000117	0.00145	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—HMOX1—atherosclerosis	0.000117	0.00144	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—CETP—atherosclerosis	0.000116	0.00144	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—LPL—atherosclerosis	0.000116	0.00143	CbGpPWpGaD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—ALB—atherosclerosis	0.000114	0.00141	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GPX1—atherosclerosis	0.000113	0.00139	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—APOB—atherosclerosis	0.000112	0.00138	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CD36—atherosclerosis	0.00011	0.00136	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	0.000108	0.00134	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—PLG—atherosclerosis	0.000104	0.00129	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—MTHFR—atherosclerosis	0.000104	0.00129	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—APOB—atherosclerosis	0.000104	0.00128	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—PLAT—atherosclerosis	0.000103	0.00127	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PPARA—atherosclerosis	0.000102	0.00126	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—AGT—atherosclerosis	9.89e-05	0.00122	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—APOE—atherosclerosis	9.69e-05	0.0012	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—HMOX1—atherosclerosis	9.64e-05	0.00119	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CAV1—atherosclerosis	9.6e-05	0.00119	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—APOA1—atherosclerosis	9.58e-05	0.00118	CbGpPWpGaD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—ALB—atherosclerosis	9.51e-05	0.00117	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—PPARA—atherosclerosis	9.43e-05	0.00117	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—APOB—atherosclerosis	9.23e-05	0.00114	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—APOA1—atherosclerosis	8.85e-05	0.00109	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—PPARA—atherosclerosis	8.76e-05	0.00108	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PIK3CG—atherosclerosis	8.75e-05	0.00108	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—PLG—atherosclerosis	8.72e-05	0.00108	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PPARG—atherosclerosis	8.44e-05	0.00104	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—INS—atherosclerosis	8.28e-05	0.00102	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—APOA1—atherosclerosis	8.21e-05	0.00101	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—HMOX1—atherosclerosis	8.04e-05	0.000994	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—PPARA—atherosclerosis	7.79e-05	0.000962	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—APOB—atherosclerosis	7.71e-05	0.000952	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ALB—atherosclerosis	7.59e-05	0.000938	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—APOA1—atherosclerosis	7.3e-05	0.000903	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—NOS3—atherosclerosis	7.26e-05	0.000897	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ALB—atherosclerosis	7.01e-05	0.000866	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PTGS2—atherosclerosis	6.64e-05	0.000821	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ALB—atherosclerosis	6.51e-05	0.000804	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—PPARA—atherosclerosis	6.5e-05	0.000803	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—APOA1—atherosclerosis	6.1e-05	0.000753	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ALB—atherosclerosis	5.79e-05	0.000715	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ALB—atherosclerosis	4.83e-05	0.000597	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—AKT1—atherosclerosis	3.34e-05	0.000412	CbGpPWpGaD
